(Q39677763)

English

The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.

scientific article published on 20 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Ichiro Nakachi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Katsuhiko Naoki

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Kenzo Soejima

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ichiro Kawada

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hideo Watanabe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hiroyuki Yasuda

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sohei Nakayama

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ryosuke Satomi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shinnosuke Ikemura

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hideki Terai

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Akitoshi Ishizaka

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Molecular Cancer Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1142-1151

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

10.1158/1541-7786.MCR-09-0388

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

release_xetx4gd4wbhthmge3yox3oaacq

1 reference

https://api.fatcat.wiki/v0/release/xetx4gd4wbhthmge3yox3oaacq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20647329%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39677763&oldid=1837088209"